Curex Pharma Private Limited, a active private limited company, was established on 08 April 2015 in New Delhi, Delhi, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U33100DL2015PTC278835. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹0.20 M.
It upholds a compliant status. Its leadership includes Ram Pher Tiwari (Director), Sarvesh Kumar (Director). Past directors included Bipin Kumar Sharma, Sanjay Ashwini Deshpande. It holds ₹5.38 M open charges and ₹6.23 M settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 10 G, 10Th Floor, Gopala Tower 25, Rajendra Place, New Delhi, Delhi, 110008.
U33100DL2015PTC278835
278835
08 April 2015
₹2.50 M
₹0.20 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Curex Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ram Pher Tiwari | Director | 25 Apr 2022 | Current |
| Sarvesh Kumar | Director | 25 Apr 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2021 | Past |
| Pramod Abcsdd | Director | 01 Apr 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Curex Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 51.64% decrease. The company also saw a substantial fall in profitability, with a 76.07% decrease in profit. The company's net worth moved up by a moderate rise of 9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Curex Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,380,000.00
₹6,225,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jul 2022 | Hdfc Bank Limited | ₹0.70 M | Satisfied |
| 01 Jun 2020 | Others | ₹0.85 M | Satisfied |
| 20 Nov 2019 | Others | ₹4.68 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Curex Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Curex Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Curex Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 27 Jul 2022 via Charge ID 100633767 with Hdfc Bank Limited was fully satisfied on 06 Nov 2025. was completed.
The activity A charge registered on 20 Nov 2019 via Charge ID 100312581 with Others was fully satisfied on 06 Nov 2025. was completed.
Curex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Progress on Curex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi. was documented.
A charge registered on 01 Jun 2020 via Charge ID 100345589 with Others was fully satisfied on 06 Jun 2024. was recorded as a recent event.
A charge with Hdfc Bank Limited amounted to Rs. 0.70 M with Charge ID 100633767 was registered on 27 Jul 2022. was recorded as a recent event.
The CIN of Curex Pharma Private Limited is U33100DL2015PTC278835.
Curex Pharma Private Limited is headquartered at 10 G, 10Th Floor, Gopala Tower 25, Rajendra Place, New Delhi, Delhi, 110008.
Curex Pharma Private Limited was incorporated on 08 April 2015.
The current directors of Curex Pharma Private Limited are
The primary industry of Curex Pharma Private Limited is Pharma.
Curex Pharma Private Limited is unlisted.
The authorized capital of Curex Pharma Private Limited is ₹2.50 M, and the paid-up capital is ₹0.20 M.
The compliance status of Curex Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX